Achieve Life Sciences
ACHV
ACHV
39 hedge funds and large institutions have $18.6M invested in Achieve Life Sciences in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
12% more capital invested
Capital invested by funds: $16.6M → $18.6M (+$1.97M)
3.21% more ownership
Funds ownership: 13.78% → 16.99% (+3.2%)
Holders
39
Holding in Top 10
1
Calls
$1.37M
Puts
$421K
Top Buyers
| 1 | +$1.54M | |
| 2 | +$1.41M | |
| 3 | +$1.12M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$822K |
| 5 |
OGC
One68 Global Capital
New York
|
+$502K |
Top Sellers
| 1 | -$990K | |
| 2 | -$642K | |
| 3 | -$338K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$94.4K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$57.1K |